未登录

M

Mihaela Johnson

Research Triangle Park

H指数:9

被引数:199

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Digital and Social Media Platform Use and Awareness of “The Real Cost” E-Cigarette Youth Prevention Campaign Ads Among U.S. Youth

数字和社交媒体平台使用以及美国青少年对“真实代价”电子烟青少年预防运动广告的认知

American Journal of Preventive Medicine

IF4.5

2026-04-290

OAAI

Amplifying Impact: FDA’s The Real Cost Youth E-Cigarette Prevention Campaign Drives Engagement With NCI’s SmokefreeTeen Vaping Cessation Resources

扩大影响：FDA的《真实成本》青少年电子烟预防宣传活动与NCI的SmokefreeTeen戒烟资源进行互动

American Journal of Preventive Medicine

IF4.5

2026-03-140

OAAI

Exploring Attention to Digital Ads: How Audiences Attend to and Respond to The Real Cost Youth E-Cigarette Prevention Campaign Ads

American Journal of Preventive Medicine

IF4.5

2026-01-300

PREAI

Cancer Survivors' and Caregivers' Understanding of FDA Accelerated Approval Disclosures

癌症幸存者和护理人员对FDA加速批准披露文件的理解

JOURNAL OF CANCER EDUCATION

IF1.3

2025-11-010

PRE

Differences Between Rural and Urban America that Inform HIV Prevention Messaging

城乡美国之间的差异及其对艾滋病预防信息的影响

AIDS AND BEHAVIOR

IF2.4

2025-05-060

PRE

End-user understanding of qualitative comparative analysis used within evidence synthesis: A mixed-methods study

最终用户对证据综合中使用的定性比较分析的理解: 一项混合方法研究

RESEARCH SYNTHESIS METHODS

IF6.1

2022-10-131

OA

Physicians' use of and preferences for FDA-approved prescribing information

医师对FDA批准的处方信息的使用和偏好

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2022-06-014

OAAI

Evaluation of a Pharmacists' Patient Care Process Approach for Hypertension

AMERICAN JOURNAL OF PREVENTIVE MEDICINE

IF4.5

2022-01-015

PRE

Development and validation of prescription drug risk, efficacy, and benefit perception measures in the context of direct-to-consumer prescription drug advertising

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2021-05-0112

OAAI

Detecting and Reporting Deceptive Prescription Drug Promotion: Differences Across Consumer and Physician Audiences and by Number and Type of Deceptive Claims and Tactics

HEALTH COMMUNICATION

IF2.7

2021-04-124

OAAI

Experimental evidence of consumer and physician detection and rejection of misleading prescription drug website content

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2021-04-0110

PREAI

Consumer responses to framing statements preceding the major risk statement in prescription drug DTC TV ads

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2020-09-015

PREAI

The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements

MEDICAL DECISION MAKING

IF2.3

2019-10-045

OAAI

Aging and Direct-to-Consumer Prescription Drug Television Ads: The Effects of Individual Differences and Risk Presentation

JOURNAL OF HEALTH COMMUNICATION

IF2.4

2019-04-239

OAAI